Zurich Cantonal Bank
ABEO icon

Zurich Cantonal Bank’s Abeona Therapeutics ABEO Stock Holding History

Zurich Cantonal Bank’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-131
Closed -$7K – 2595
2019
Q3 		$7K Hold
131
– – ﹤0.01% 2579
2019
Q2 		$16K Hold
131
– – ﹤0.01% 2509
2019
Q1 		$24K Hold
131
– – ﹤0.01% 2362
2018
Q4 		$23K Hold
131
– – ﹤0.01% 2400
2018
Q3 		$42K Buy
131
+56
+75% +$19.9K ﹤0.01% 2237
2018
Q2 		$30K Buy
+75
New +$32.8K ﹤0.01% 2336

Other funds holding ABEO

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Zurich Cantonal Bank's ABEO Position: Q4 2019 in Review

Zurich Cantonal Bank sold out of Abeona Therapeutics (ABEO) in Q4 2019, closing a stake of 131 shares — an estimated $7K sold.

Zurich Cantonal Bank first reported a position in ABEO in Q2 2018 and held it in 6 quarters. The position peaked at $42K in Q3 2018. 87 funds tracked by Wall St. Rank hold ABEO as of Q4 2019.

  • Zurich Cantonal Bank reported no remaining Abeona Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Zurich Cantonal Bank sold 131 Abeona Therapeutics shares in Q4 2019, an estimated $7K.
  • Zurich Cantonal Bank first reported a position in Abeona Therapeutics in Q2 2018 and held it in 6 quarters.
  • Zurich Cantonal Bank's Abeona Therapeutics position peaked at $42K in Q3 2018.
  • 87 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2019.

Based on Zurich Cantonal Bank's 13F filing for Q4 2019, filed 21 Jan 2020.